Hemophilic arthropathy. Current concepts of pathogenesis and management.
D000293:Adolescent; D000328:Adult; D000700:Analgesics / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001168:Arthritis / Q000209:etiology / Q000628:therapy; D001174:Arthrodesis; D001178:Arthroplasty; D002648:Child; D005164:Factor IX / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D006395:Hemarthrosis / Q000209:etiology / Q000628:therapy; D006467:Hemophilia A / Q000150:complications* / Q000503:physiopathology; D006621:Hip Joint; D006801:Humans; D007595:Joint Prosthesis; D007719:Knee Joint; D008297:Male; D010024:Osteoporosis / Q000209:etiology; D013583:Synovial Membrane / Q000473:pathology
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000933:Antifibrinolytic Agents; D005169:Factor VIII; D005164:Factor IX